Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant
New Biotechnology · 2025
DOI: 10.1016/j.nbt.2025.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Biotechnology, 2025. Verfasst von Koki Murozono und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Fukuoka 819-0395, Japan. Hauptthemen laut MEDLINE: Immunoglobulin Fab Fragments, Immunoglobulin G. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The fragment antigen-binding (Fab) fragment of IgG has been studied widely as a delivery vehicle for tumor-targeting drugs and dyes due to its high specificity and enhanced tumor penetration, which is attributed to its small size. Functionalizing Fab with chemical entities requires site-specific modification to preserve the binding ninity and ensure product homogeneity. In this study, we report a tag-free, site-specific labeling approach targeting a Lys residue in Fab using the recently developed engineered zymogen of microbial transglutaminase fused with an antibody-binding protein G. Fab of trastuzumab, prepared via papain digestion, was selectively modified at Lys 65 in the heavy chain with a glutamine-donor fluorescent substrate, achieving a high labeling efficiency (∼96 %). Bio-layer interferometry experiments confirmed that the modified Fab retained antigen-binding affinity (KD = 5.71 ± 3.89 nM) comparable to its native counterpart (4.72 ± 3.19 nM). Confocal microscopy analysis demonstrated selective binding of the fluorescent-modified Fab to human epidermal growth factor receptor type2 (HER2)-positive SK-BR-3 cells, with negligible binding to HER2-negative MDA-MB-231 cells. The proposed strategy enables site-specific Fab modification without genetic engineering, offering a streamlined approach to producing homogeneous Fab conjugates for diagnostic imaging and therapeutic antibody engineering applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Fukuoka 819-0395, Japan.
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Fukuoka 819-0395, Japan; Division of Biotechnology, Center for Future Chemistry, Kyushu University, 744 Motooka, Fukuoka 8…
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Murozono, K., Nishioka, R., Kawaguchi, Y., Kimura, M., & Kamiya, N. (2025). Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant. New Biotechnology. https://doi.org/10.1016/j.nbt.2025.08.004
Vancouver
Murozono K, Nishioka R, Kawaguchi Y, Kimura M, Kamiya N. Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant. New Biotechnology. 2025. doi:10.1016/j.nbt.2025.08.004
BibTeX
@article{Murozono2025,
author = {Murozono, Koki and Nishioka, Riko and Kawaguchi, Yoshirou and Kimura, Michio and Kamiya, Noriho},
title = {Proximity-based site-specific labeling of a native IgG Fab fragment by a fusion microbial transglutaminase-protein G variant},
journal = {New Biotechnology},
year = {2025},
doi = {10.1016/j.nbt.2025.08.004}
}
EUVIMED